The interactions between beta-blockers and anaesthetics. Experimental observations

Area of Science:

• Cardiology
• Anesthesiology
• Pharmacology

Background:

• Beta-adrenoceptor antagonists (beta-blockers) are vital for managing hypertension and ischemic heart disease.
• Maintaining beta-blockade avoids cardiac risks and controls sympathetic overactivity.
• Beta-blocker use influences anesthetic agent selection due to potential drug interactions.

Purpose of the Study:

• To investigate the interactions between beta-blockers and various anesthetic agents.
• To assess the impact of these interactions on cardiovascular performance in patients with specific heart conditions.
• To evaluate the myocardial protective effects of beta-blockade during anesthesia in the presence of coronary artery disease.

Main Methods:

• Review of existing literature on beta-blocker and anesthetic drug interactions.
• Analysis of studies examining cardiovascular responses to different anesthetic agents in patients on beta-blockers.
• Evaluation of recent research on myocardial function under anesthesia with narrowed coronary arteries.

Main Results:

• No adverse interactions observed with halothane, halothane/nitrous oxide, or isoflurane anesthesia.
• Significant cardiac performance reductions noted with methoxyflurane or trichloroethylene anesthesia.
• Adverse interaction with propranolol and enflurane, but not oxprenolol and enflurane.
• Halothane and enflurane can cause myocardial dysfunction in narrowed coronary arteries.
• Oxprenolol minimized this dysfunction and appears to offer myocardial protection.

Conclusions:

• Anesthetic management requires careful consideration of beta-blocker interactions.
• Methoxyflurane, trichloroethylene, and certain combinations (propranolol/enflurane) pose risks.
• Beta-blockade, particularly with agents like oxprenolol, may protect the myocardium in patients with ischemic heart disease.